190 related articles for article (PubMed ID: 18343944)
1. Liver metastasis as an initial recurrence has no impact on the survival of patients with resectable pancreatic adenocarcinoma.
Tani M; Kawai M; Miyazawa M; Hirono S; Ina S; Nishioka R; Fujita Y; Uchiyama K; Yamaue H
Langenbecks Arch Surg; 2009 Mar; 394(2):249-53. PubMed ID: 18343944
[TBL] [Abstract][Full Text] [Related]
2. Resection of pancreatic ductal adenocarcinoma with synchronous distant metastasis: is it worthwhile?
Buc E; Orry D; Antomarchi O; Gagnière J; Da Ines D; Pezet D
World J Surg Oncol; 2014 Nov; 12():347. PubMed ID: 25407113
[TBL] [Abstract][Full Text] [Related]
3. The lymph node ratio is the strongest prognostic factor after resection of pancreatic cancer.
Riediger H; Keck T; Wellner U; zur Hausen A; Adam U; Hopt UT; Makowiec F
J Gastrointest Surg; 2009 Jul; 13(7):1337-44. PubMed ID: 19418101
[TBL] [Abstract][Full Text] [Related]
4. Para-aortic node involvement is not an independent predictor of survival after resection for pancreatic cancer.
Sperti C; Gruppo M; Blandamura S; Valmasoni M; Pozza G; Passuello N; Beltrame V; Moletta L
World J Gastroenterol; 2017 Jun; 23(24):4399-4406. PubMed ID: 28706422
[TBL] [Abstract][Full Text] [Related]
5. Effect of multiple-phase regional intra-arterial infusion chemotherapy on patients with resectable pancreatic head adenocarcinoma.
Jin C; Yao L; Long J; Fu DL; Yu XJ; Xu J; Yang F; Ni QX
Chin Med J (Engl); 2009 Feb; 122(3):284-90. PubMed ID: 19236805
[TBL] [Abstract][Full Text] [Related]
6. Greater lymph node retrieval and lymph node ratio impacts survival in resected pancreatic cancer.
Mirkin KA; Hollenbeak CS; Wong J
J Surg Res; 2017 Dec; 220():12-24. PubMed ID: 29180173
[TBL] [Abstract][Full Text] [Related]
7. Rationale of the so-called extended resection for pancreatic invasive ductal carcinoma.
Imamura M; Hosotani R; Kogire M
Digestion; 1999; 60 Suppl 1():126-9. PubMed ID: 10026446
[TBL] [Abstract][Full Text] [Related]
8. Impact of preoperative therapy on patterns of recurrence in pancreatic cancer.
Papavasiliou P; Hoffman JP; Cohen SJ; Meyer JE; Watson JC; Chun YS
HPB (Oxford); 2014 Jan; 16(1):34-9. PubMed ID: 23458131
[TBL] [Abstract][Full Text] [Related]
9. Splenic hilar lymph node metastasis independently predicts poor survival for patients with gastric cancers in the upper and/or the middle third of the stomach.
Zhu GL; Sun Z; Wang ZN; Xu YY; Huang BJ; Xu Y; Zhu Z; Xu HM
J Surg Oncol; 2012 Jun; 105(8):786-92. PubMed ID: 22105768
[TBL] [Abstract][Full Text] [Related]
10. Patterns of recurrence after curative resection of pancreatic cancer, based on autopsy findings.
Hishinuma S; Ogata Y; Tomikawa M; Ozawa I; Hirabayashi K; Igarashi S
J Gastrointest Surg; 2006 Apr; 10(4):511-8. PubMed ID: 16627216
[TBL] [Abstract][Full Text] [Related]
11. Survival Impact of Pulmonary Metastasis as Recurrence of Pancreatic Ductal Adenocarcinoma.
Yamashita K; Miyamoto A; Hama N; Asaoka T; Maeda S; Omiya H; Takami K; Doki Y; Mori M; Nakamori S
Dig Surg; 2015; 32(6):464-71. PubMed ID: 26517228
[TBL] [Abstract][Full Text] [Related]
12. Long-term survival after resection of pancreatic ductal adenocarcinoma with para-aortic lymph node metastasis: case report.
Masui T; Kubota T; Aoki K; Nakanishi Y; Miyamoto T; Nagata J; Morino K; Fukugaki A; Takamura M; Sugimoto S; Onuma H; Tokuka A
World J Surg Oncol; 2013 Aug; 11(1):195. PubMed ID: 23945441
[TBL] [Abstract][Full Text] [Related]
13. An aggressive therapeutic approach to carcinoma of the body and tail of the pancreas.
Ozaki H; Kinoshita T; Kosuge T; Yamamoto J; Shimada K; Inoue K; Koyama Y; Mukai K
Cancer; 1996 Jun; 77(11):2240-5. PubMed ID: 8635090
[TBL] [Abstract][Full Text] [Related]
14. Liver perfusion chemotherapy via both the hepatic artery and portal vein to prevent hepatic metastasis after extended pancreatectomy for adenocarcinoma of the pancreas.
Ishikawa O; Ohigashi H; Sasaki Y; Furukawa H; Kabuto T; Kameyama M; Nakamori S; Hiratsuka M; Imaoka S
Am J Surg; 1994 Oct; 168(4):361-4. PubMed ID: 7943597
[TBL] [Abstract][Full Text] [Related]
15. [Oncologic risk in pylorus preservation in resection of ductal pancreas carcinoma].
Gerdes B; Ramaswamy A; Bartsch D; Rothmund M
Langenbecks Arch Chir Suppl Kongressbd; 1997; 114():1087-9. PubMed ID: 9574341
[TBL] [Abstract][Full Text] [Related]
16. The role of paraaortic lymph node involvement on early recurrence and survival after macroscopic curative resection with extended lymphadenectomy for pancreatic carcinoma.
Shimada K; Sakamoto Y; Sano T; Kosuge T
J Am Coll Surg; 2006 Sep; 203(3):345-52. PubMed ID: 16931307
[TBL] [Abstract][Full Text] [Related]
17. Clinical and pathological features of five-year survivors after pancreatectomy for pancreatic adenocarcinoma.
Kimura K; Amano R; Nakata B; Yamazoe S; Hirata K; Murata A; Miura K; Nishio K; Hirakawa T; Ohira M; Hirakawa K
World J Surg Oncol; 2014 Nov; 12():360. PubMed ID: 25429841
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of preoperative prognostic factors in patients with resectable pancreatic ductal adenocarcinoma.
Izumo W; Higuchi R; Furukawa T; Yazawa T; Uemura S; Shiihara M; Yamamoto M
Scand J Gastroenterol; 2019 Jun; 54(6):780-786. PubMed ID: 31180790
[No Abstract] [Full Text] [Related]
19. Oncologic outcomes of laparoscopy-assisted distal gastrectomy for gastric cancer.
Fukunaga T; Hiki N; Kubota T; Nunobe S; Tokunaga M; Nohara K; Sano T; Yamaguchi T
Ann Surg Oncol; 2013 Aug; 20(8):2676-82. PubMed ID: 23709054
[TBL] [Abstract][Full Text] [Related]
20. Extended pancreatectomy and liver perfusion chemotherapy for resectable adenocarcinoma of the pancreas.
Ishikawa O; Ohhigashi H; Sasaki Y; Furukawa H; Imaoka S
Digestion; 1999; 60 Suppl 1():135-8. PubMed ID: 10026448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
